Evidence map›Paper›PMID 33719200›Full record

ArticleOrthopaedic surgery2021

Exciting Performance of Plasma Fibrinogen in Periprosthetic Joint Infection Diagnosis.

Jin-Cheng Huang, Xiao Chen, Shuo Qiang, Wen-di Zheng, Jia Zheng, Yi Jin

Open access · goldAbstract read
In one paragraph

Article in Orthopaedic surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Role of Biomarkers in Periprosthetic Joint Infections.Diagnostics (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jin-Cheng HuangDepartment of Orthopaedics, Henan Provincial People's Hospital, Zhengzhou, China.ORCID https://orcid.org/0000-0002-2084-963X
Xiao ChenDepartment of Orthopaedics, People's Hospital of Zhengzhou University, Zhengzhou, China.
Shuo QiangDepartment of Orthopaedics, Henan Provincial People's Hospital, Zhengzhou, China.
Wen-di ZhengDepartment of Orthopaedics, Henan Provincial People's Hospital, Zhengzhou, China.
Jia ZhengDepartment of Orthopaedics, Henan Provincial People's Hospital, Zhengzhou, China.ORCID https://orcid.org/0000-0002-5184-7514
Yi JinDepartment of Orthopaedics, Henan Provincial People's Hospital, Zhengzhou, China.
Henan Provincial People's Hospital · CNHealth First · USZhengzhou University · CN

Funding

Key scientific and technological projects in Henan Province 202102310113Ministry of Science and Technology National Key Research and Development Program 2017YFB1104100National Natural Science Foundation of China 82002840
6 · The paper itself

Abstract

objectiveTo test the significance of serum C-reactive protein (CRP), the erythrocyte sedimentation rate (ESR), the platelet count/mean platelet volume ratio (PC/MPV), plasma fibrinogen, and D-Dimer in periprosthetic joint infection (PJI) diagnosis.

methodsWe retrospectively analyzed the clinical data of 149 patients diagnosed from July 2016 to December 2019 with primary osteoarthritis (OA group, average age 63.18 years [range, 53-82 years] 18 males, 46 females), PJI (PJI group, average age 63.74 years [range, 52-81 years], 16 males, 31 females), and aseptic loosening (aseptic group, average age 63.18 years [range, 53-80 years], 12 male, 26 female) in our department. Demographic data and the sensitivity and specificity of preoperative CRP, ESR, PC/MPV, fibrinogen, and D-Dimer in PJI diagnosis were compared.

resultsThere were no significant differences when the demographic data of the three groups were compared. The expression level of CRP (50.67 ± 58.98 mg/L), ESR (50.55 ± 25.81 mm/h), PC/MPV (35.79 ± 18.00), and fibrinogen (4.85 ± 1.33 μg/mL) in the PJI group were higher than in the OA group (CRP: 4.09 ± 9.68 mg/L; ESR:13.44 ± 9.32 mm/1 h; PC/MPV: 24.97 ± 7.58; fibrinogen: 3.09 ± 0.55 μg/mL) and the aseptic group (CRP: 7.01 ± 11.83 mg/L; ESR: 22.47 ± 17.53 mm/1 h; PC/MPV: 25.18 ± 11.48; fibrinogen: 3.39 ± 0.80 μg/mL), respectively. The expression level of plasma D-dimer (1.60 ± 1.29 mg/L) in the PJI group was higher than in the OA group (0.49 ± 0.42 mg/L) but similar to that in the aseptic group (1.21 ± 1.35 mg/L). Receiver operating characteristic (ROC) curve analysis demonstrated that the areas under the ROC curve (AUC) for CRP, ESR, PC/MPV, fibrinogen, and D-dimer were 0.892 (95% confidence interval, 0.829-0.954), 0.888 (0.829-0.947), 0.686 (0.589-0.784), 0.873 (0.803-0.943), and 0.835 (0.772-0.899), respectively. When PC/MPV > 31.70, fibrinogen >4.01 μg/mL, and D-dimer >1.17 mg/L were set as the threshold values for the diagnosis of PJI, the sensitivity of PC/MPV in PJI diagnosis was lower than that of ESR and plasma fibrinogen. In contrast, there was no significant difference when comparing the specificity of CRP, ESR, PC/MPV, fibrinogen, and D-dimer in PJI diagnosis.

conclusionPlasma fibrinogen is a good new auxiliary diagnostic marker for PJI.

Indexed as

Blood SedimentationPlatelet CountAgedAged, 80 and overBiomarkersC-Reactive ProteinFemaleFibrin Fibrinogen Degradation ProductsFibrinogenHumansMaleMiddle AgedProsthesis-Related InfectionsBiomarkersC-Reactive ProteinFibrin Fibrinogen Degradation Productsfibrin fragment DFibrinogenD-dimerDiagnosisFibrinogenPeriprosthetic joint infectionPlatelets

Identifiers

PMID33719200
PMCPMC8126952
OpenAlexW3137088608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.